AHR and experimental autoimmune encephalomyelitis: These results correlate with the hypothesis that due to stronger binding of FICZ to the AhRLBD active site it is able to activate AhR during TH17 cell development thereby markedly increasing the proportion of TH17 T cells, production of cytokines and exacerbated disease in experimental autoimmune encephalomyelitis [10].